+467.0%
MRNA vs FCUV
-94.5%
+561.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FCUV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +3.3% | +2.1% | +5.4% |
| 7D | -1.1% | -66.5% | +65.4% | -1.6% |
| 30D | +126.1% | +5.0% | +121.1% | +127.5% |
| 3M | +190.0% | +63.8% | +126.2% | +203.4% |
| 6M | +157.2% | -67.8% | +225.1% | +174.1% |
| YTD | +388.2% | -82.4% | +470.6% | +433.3% |
| 1Y | +467.0% | -94.7% | +561.8% | +563.4% |
| All | +467.0% | -94.5% | +561.5% | +563.4% |
Cumulative growth
Daily Returns
Daily percentage return beside FCUV.
Daily Out/Under-Performance
Portfolio return minus FCUV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FCUV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FCUV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling